EB
Eucrates Biomedical Acquisition Corp. Stock: price and insider trades · United States
Eucrates Biomedical Acquisition Corp.: what insiders have been doing
Eucrates Biomedical Acquisition Corp. has a thin disclosure history in our data (latest filing: 27 November 2020). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2022FY ended December 2022 · cache
Income statement
Net income2.2M
Last declaration on 27 November 2020
Declarations3 total
- 255,094 sharesOrdinary SharesSEC:0001104659-20-130014:0
- 255,094 sharesOrdinary SharesSEC:0001104659-20-130016:0
- 255,094 sharesOrdinary SharesSEC:0001104659-20-130017:0
3 of 3 declarations
About Eucrates Biomedical Acquisition Corp.
Eucrates Biomedical Acquisition Corp. is a special purpose acquisition company focused on the biotechnology sector. It is listed on NASDAQ.
